user

Hematological adverse events as predictors of response to pegylated interferon and ribavirin treatment in patients with chronic hepatitis C genotype 4

被引：0
|
作者：
Taha, A. [1 ]
Hasan, M. [1 ]
Samir, A. [2 ]
Kandil, A. [2 ]
El-Sisi, E. [2 ]
Yilmaz, N. [3 ]
机构：
[1] Theodor Bilharz Res Inst, Cairo, Egypt
[2] Minist Hlth Cairo, October Hosp 6, Cairo, Egypt
[3] Mugla Univ, Mugla, Turkey
来源：
JOURNAL OF VIRAL HEPATITIS | 2013年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：24 / 24
页数：1
相关论文
共 50 条
  • [1] Response to Pegylated Interferon Alfa-2a and Ribavirin in Chronic Hepatitis C Genotype 4
    El Makhzangy, Hesham
    Esmat, Gamal
    Said, Mohamed
    ElRaziky, Maissa
    Shouman, Soheir
    Refai, Rasha
    Rekacewicz, Claire
    Gad, Rita Raafat
    Vignier, Nicolas
    Abdel-Hamid, Mohamed
    Zalata, Khaled
    Bedossa, Pierre
    Pol, Stanislas
    Fontanet, Arnaud
    Mohamed, Mostafa K.
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2009, 81 (09) : 1576 - 1583
  • [2] Merimepodib, Pegylated Interferon, and Ribavirin in Genotype 1 Chronic Hepatitis C Pegylated Interferon and Ribavirin Nonresponders
    Rustgi, Vinod K.
    Lee, William M.
    Lawitz, Eric
    Gordon, Stuart C.
    Afdhal, Nezam
    Poordad, Fred
    Bonkovsky, Herbert L.
    Bengtsson, Leif
    Chandorkar, Gurudatt
    Harding, Matthew
    McNair, Lindsay
    Aalyson, Molly
    Alam, John
    Kauffman, Robert
    Gharakhanian, Shahin
    McHutchison, John G.
    [J]. HEPATOLOGY, 2009, 50 (06) : 1719 - 1726
  • [3] PREDICTORS OF SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN
    Paci, M.
    Lorefice, E.
    Gianni, E.
    Renzo, S.
    Capanni, M.
    Forte, P.
    Milani, S.
    Surrenti, C.
    [J]. DIGESTIVE AND LIVER DISEASE, 2008, 40 : S113 - S113
  • [4] INSULIN RESISTANCE AND GEOGRAPHICAL ORIGIN ARE MAJOR PREDICTORS OF LIVER FIBROSIS AND RESPONSE TO PEGYLATED INTERFERON AND RIBAVIRIN IN GENOTYPE 4 CHRONIC HEPATITIS C PATIENTS
    Moucari, R.
    Ripault, M. -P.
    Martinot-Peignoux, M.
    Castelnau, C.
    Voitot, H.
    El Ray, A.
    Asselah, T.
    Boyer, N.
    Vidaud, M.
    Bedossa, P.
    Valla, D.
    Marcellin, P.
    [J]. JOURNAL OF HEPATOLOGY, 2009, 50 : S233 - S234
  • [5] Hepatitis C genotype 4 response rate to pegylated interferon and ribavirin treatment in Belgium is similar to genotype 1
    de Galocsy, C.
    Kaufman, L.
    Tomasovic, S.
    Delwaide, J.
    Nevens, F.
    [J]. ACTA GASTRO-ENTEROLOGICA BELGICA, 2010, 73 (02): : 229 - 234
  • [6] Insulin resistance, fibrosis and genotype are predictors of sustained response rate to pegylated interferon plus ribavirin in patients with chronic hepatitis C
    Romero-Gomez, M
    Viloria, MM
    Corpas, R
    Cruz, M
    Sanchez-Munoz, D
    Grande, L
    Castillo, J
    Suarez, E
    Camacho, I
    Nogales, MC
    [J]. JOURNAL OF HEPATOLOGY, 2004, 40 : 150 - 150
  • [7] Chronic hepatitis C virus genotype 6 infection: Response to pegylated interferon and ribavirin
    Fung, James
    Lai, Ching-Lung
    Hung, Ivan
    Young, John
    Cheng, Charles
    Wong, Danny
    Yuen, Man-Fung
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2008, 198 (06): : 808 - 812
  • [8] Response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C due to genotype 4
    Martin-Carbonero, L.
    Puoti, M.
    Garcia-Samaniego, J.
    De Luca, A.
    Losada, E.
    Quinzan, G.
    Bruno, R.
    Marino, A.
    Gonzalez, M.
    Nunez, M.
    Soriano, V.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2008, 15 (10) : 710 - 715
  • [9] Sustained virological response of pegylated interferon α-2A plus ribavirin in patients with chronic hepatitis C genotype 4
    Shiha, G
    Gabre, M
    Zalata, K
    Sayed, S
    [J]. GUT, 2004, 53 : A81 - A81
  • [10] Pegylated Interferon and Ribavirin for the Treatment of Chronic Hepatitis C
    Kemp, William
    Roberts, Stuart
    [J]. CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2011, 3 : 137 - 150
12345